BrightEdge is the innovation, impact investment and venture capital arm of the American Cancer Society. Today, our ACS Impact Venture Fund (AIVF) invests in for-profit, early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies to fuel and accelerate ACS’s mission of ending cancer as we know it, for everyone.
The mission of the Kenneth King Foundation is to create opportunities for those in need. Based in Colorado, our focus is removing barriers to employment, opening pathways to meaningful employment and creating opportunities for enterpreneurship.
